Wanbury
WANBURYNSE

Wanbury

₹239.35-2.10 (0.87%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
234.75
Today’s high
240.40
52 week low
161.50
52 week high
358.85
Open price
240.00
Previous close
241.45
Live volume
59,568
Lower circuit
191.50
Upper circuit
287.20

Fundamentals

Market Cap
₹846Cr
ROE
45.78%
P/E Ratio(TTM)
15.14
EPS(TTM)
15.98
P/B Ratio
5.86
Dividend Yield
0.00%
Industry P/E
51.19
Book Value
41.32
Debt to Equity
1.55
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
JUN '26
Revenue (Cr)
₹166
+0.70%
Profit (Cr)
₹3.24
-85.07%
050100150200
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Revenue growthValue
1Y (TTM)+1%
3Y CAGR+9%
Profit growthValue
1Y (TTM)-76%
3Y CAGR+103%

About

Wanbury Limited is a leading pharmaceutical company specializing in Active Pharmaceutical Ingredients (API) and Formulations. It is one of the world's largest producers of Metformin (anti-diabetic). The company successfully completed its first commercial shipment of high-potency anaesthetic APIs to the European market from its state-of-the-art Tanaku facility.;
CEO/MD
Mr. Mohan Kumar Rayana
Founded in
1988
NSE symbol
WANBURY

Shareholding pattern

Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Shareholder details

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
₹2,754.90
-40.50 (1.45%)
L
    H
    21,230.0731.316.3
    PfizerPFIZER
    ₹4,060.20
    -35.20 (0.86%)
    L
      H
      18,739.4125.494.46
      ₹6,764.50
      -96.00 (1.40%)
      L
        H
        17,146.63101.0919.65
        ₹1,025.20
        -0.45 (0.04%)
        L
          H
          16,339.4046.52.3
          Livesquawk
          Wanbury gets EDQM approval for Rivaroxaban API. USFDA clears DMFs for Paroxetine HCL and Metformin HCL.
          Livesquawk
          Wanbury confirms no DMF issues from USFDA for multiple ANDAs. Firm exploring South Korean market to expand API supply.
          2026
          11
          Aug
          Quarterly Result
          Release date
          29
          May
          Quarterly & Annual Result
          Release date
          14
          May
          Quarterly & Annual Result
          Release date
          5
          Feb
          Quarterly Result
          Release date
          2025
          13
          Nov
          Quarterly Result
          Release date
          4
          Aug
          Quarterly Result
          Release date
          Events calendar
          View upcoming events in other stocks